Comments on: CHMP opinions: EMA refuses asthma label expansion for GSK’s COPD drug Trelegy Ellipta

Comments on: CHMP opinions: EMA refuses asthma label expansion for GSK’s COPD drug Trelegy Ellipta /news/ema-gsk-trelegy-asthma-refusal/ The leading site for news and procurement in the pharmaceutical industry Mon, 01 Mar 2021 16:35:23 +0000 hourly 1 https://wordpress.org/?v=6.6.1